Cargando…
Advance of Mesenchymal Stem Cells in Chronic End-Stage Liver Disease Control
The chronic liver diseases will slowly develop into liver fibrosis, cirrhosis, and even liver cancer if no proper control is performed with high efficiency. Up to now, the most effective treatment for end-stage liver diseases is liver transplantation. However, liver transplantation has the problems...
Autores principales: | Gao, Yun, Yin, Xiushan, Ren, Xiaomeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568364/ https://www.ncbi.nlm.nih.gov/pubmed/36248254 http://dx.doi.org/10.1155/2022/1526217 |
Ejemplares similares
-
Stem cell transplantation for the treatment of end-stage liver disease
por: Wu, Dong-Bo, et al.
Publicado: (2018) -
Enhanced infection efficiency and cytotoxicity mediated by vpx-containing lentivirus in chimeric antigen receptor macrophage (CAR-M)
por: Gao, Yun, et al.
Publicado: (2023) -
Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease
por: Salama, Hosny, et al.
Publicado: (2014) -
Transplantation of Autologous Mesenchymal Stem Cells for End-Stage Liver Cirrhosis: A Meta-Analysis Based on Seven Controlled Trials
por: Ma, Xiang-Rui, et al.
Publicado: (2015) -
Clinical application of stem cell in patients with end-stage liver disease: progress and challenges
por: Tao, Ya-Chao, et al.
Publicado: (2020)